Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > Interesting....
View:
Post by mercedesman on Mar 21, 2022 9:35am

Interesting....

...a pinch hitting bean counter that has experience as a VP Finance of a Company that was acquired by another Company? 

Seems like Seto was looking for some pretty specific knowledge/M&A experieince from the perspective of the acquiree, vs a long time CFO who can run a couple of distribution Companies.

Failing that, the new guy is familiar with the reporting/listing requirements of a Nasdaq listed company.

Which fork in the road will Seto take as the two Trials/FDA move inexorably toward completion?

Hmmmm?!?

MM
Comment by Domino55 on Mar 21, 2022 12:05pm
This to me looks like another administrative release. It is sufficiently vague. Is it a subtle indicator of where things are headed? Hard to say in the context of the blind puzzle. Real news is long overdue.
Comment by mercedesman on Mar 21, 2022 12:16pm
I'm guessing that there will be 1 - 2  puzzle peices released by the end of this week (worst case, the week following)
Comment by Accountprince on Mar 21, 2022 12:28pm
MM - I agree that pieces will fall into place in the short term.  All the missing info and disclosures will need to be brought up to date.  There seems to be a sense that something has been or is in the works. Although the new CFO has NASDAQ experience they highlight his experience in taking the company he worked for private from the NASDAQ.  I feel if they wanted to do a NASDAQ ...more  
Comment by mercedesman on Mar 21, 2022 12:55pm
Some good points AP You mean full disclosure, on certain issues, when it serves a purpose, I assume? Agree on Nasdaq...perhaps they need to show potential buyers that they have a secondary endgame option if the price isn't right? There ceases to be a need for a Company (much less a public one) once you have sold off your NA Rights X 2 (and your worldwide rights X 1).  Clean-up on aisle ...more  
Comment by Domino55 on Mar 21, 2022 12:52pm
MM I'm  not sure we get real  news until we get this gentleman suited up with options.  Hopefully he has been loaded up and we can move forward.
Comment by mercedesman on Mar 21, 2022 12:59pm
Thought about that. If he was worth his salt, he would already have negotiated that in his contract. Otherwise he has a small but specific role to play IMO. Material developments can only be sat on for so long. MM
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities